Today AstraZenica announced late stage trials of its COVID-19 vaccine with Oxford University Senator Steve Daines participated with in it tests could be up to 90% effective against the coronavirus. Chief Executive Officer Pascal Soriot says a possible trial of the half dose regimen could come to the U.S. before the end of the year.
Categories: COVID-19 News, News Headlines